A case of thymic Langerhans cell histiocytosis with diabetes insipidus as the first presentation

Front Med. 2013 Mar;7(1):143-6. doi: 10.1007/s11684-013-0238-6. Epub 2012 Dec 28.

Abstract

Langerhans cell histiocytosis (LCH) is an idiopathic group of reactive proliferative diseases linked to aberrant immunity, pathologically characterized by clonal proliferation of Langerhans cells. LCH rarely involves the thymus. We report a case of thymic LCH with diabetes insipidus as the first presentation, without evidence of myasthenia gravis and without evidenced involvement of the skin, liver, spleen, bones, lungs and superficial lymph nodes. This present case may have important clinical implications. In screening for LCH lesions, attention should be attached to rarely involved sites in addition to commonly involved organs. Follow-up and imageological examination are very important to a final diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antidiuretic Agents / administration & dosage
  • Deamino Arginine Vasopressin / administration & dosage
  • Diabetes Insipidus* / diagnosis
  • Diabetes Insipidus* / etiology
  • Diabetes Insipidus* / physiopathology
  • Diabetes Insipidus* / therapy
  • Histiocytosis, Langerhans-Cell* / complications
  • Histiocytosis, Langerhans-Cell* / diagnosis
  • Histiocytosis, Langerhans-Cell* / physiopathology
  • Histiocytosis, Langerhans-Cell* / therapy
  • Humans
  • Immunohistochemistry
  • Langerhans Cells / pathology*
  • Magnetic Resonance Imaging / methods
  • Male
  • Pituitary Gland / pathology
  • Pituitary Gland / physiopathology
  • Thymectomy / methods
  • Thymus Gland* / pathology
  • Thymus Gland* / surgery
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Antidiuretic Agents
  • Deamino Arginine Vasopressin